Similarly, recombinant IL-33 was also observed to significantly reduce the nuclear translocation of NF-κB and disrupt its downstream pro-inflammatory mechanisms in monocytes derived from patients with AD and mild cognitive impairment (MCI) in vitro [47] (Fig. 2). The gene discussed is IL33; the disease is Alzheimer disease.